Literature DB >> 20430561

Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatographic-mass spectrometry and the application to pharmacokinetics in rats.

Yun Liu1, Xiaorong Li, Yuhang Li, Lijuan Wang, Ming Xue.   

Abstract

A sensitive and specific liquid chromatography-tandem mass spectrometry method (LC-MS) was developed and validated for the separation and simultaneous determination of danshensu, rosmarinic acid and tanshinone compounds including cryptotanshinone, tanshinone I, dihydrotanshinone I and tanshinone IIA in rat plasma. Chromatographic separation of the analytes was successfully achieved on a C(18) column using a mobile phase composed of acetonitrile-water containing 0.5% glacial acetic acid. This method demonstrated good linearity and did not have endogenous material interfering with the active compounds and I.S. peaks. The limit of quantification of danshensu, rosmarinic acid, cryptotanshinone, dihydrotanshinone I, tanshinone I and tanshinone IIA were 5, 0.75, 0.1, 0.1, 1 and 0.5 ng/mL. The average extraction recoveries of these analytes from rat plasma were all over 60%. The precisions determined from five days were all within 10%. This method has been successfully applied in the simultaneous quantification and the pharmacokinetic studies of these six compounds in animals which were orally administered with danshen preparations. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430561     DOI: 10.1016/j.jpba.2010.03.041

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro.

Authors:  Weidong Li; Shakir M Saud; Matthew R Young; Nancy H Colburn; Baojin Hua
Journal:  Mol Cell Biochem       Date:  2015-04-26       Impact factor: 3.396

2.  The Multivariate Regression Statistics Strategy to Investigate Content-Effect Correlation of Multiple Components in Traditional Chinese Medicine Based on a Partial Least Squares Method.

Authors:  Ying Peng; Su-Ning Li; Xuexue Pei; Kun Hao
Journal:  Molecules       Date:  2018-03-01       Impact factor: 4.411

3.  Simultaneous Determination of Twenty-Five Compounds in Rat Plasma Using Ultra-High Performance Liquid Chromatography-Polarity Switching Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study.

Authors:  Na Zhang; Yueting Li; Jing Sun; Chun Li; Yuelin Song; Jun Li; Pengfei Tu; Yunfang Zhao
Journal:  Molecules       Date:  2017-10-30       Impact factor: 4.411

4.  High-Throughput Determination of Sodium Danshensu in Beagle Dogs by the LCMS/MS Method, Employing Liquid-Liquid Extraction Based on 96-Well Format Plates.

Authors:  Jingjing Jiang; Xin Zhao; Xiuxiu Li; Shengyuan Wu; Shidan Yu; Yuefen Lou; Guorong Fan
Journal:  Molecules       Date:  2017-04-25       Impact factor: 4.411

Review 5.  Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets.

Authors:  Jie Liu; Yun Shi; Daiyin Peng; Lei Wang; Nianjun Yu; Guokai Wang; Weidong Chen
Journal:  Front Cardiovasc Med       Date:  2022-04-22

Review 6.  Research and Development of Natural Product Tanshinone I: Pharmacology, Total Synthesis, and Structure Modifications.

Authors:  Xing Huang; Lili Jin; Hao Deng; Dan Wu; Qing-Kun Shen; Zhe-Shan Quan; Chang-Hao Zhang; Hong-Yan Guo
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

Review 7.  Tanshinones: sources, pharmacokinetics and anti-cancer activities.

Authors:  Yong Zhang; Peixin Jiang; Min Ye; Sung-Hoon Kim; Cheng Jiang; Junxuan Lü
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

8.  A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease.

Authors:  Shao-hua Shi; Yue-piao Cai; Xiao-jun Cai; Xiao-yong Zheng; Dong-sheng Cao; Fa-qing Ye; Zheng Xiang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.